Original Research

Published on 24 Jan 2024

The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study

in Drugs Outcomes Research and Policies

Carole Bandiera
Jennifer Dotta-Celio
Isabella Locatelli
Dina Nobre
Grégoire Wuerzner
Menno Pruijm
Faiza Lamine
Michel Burnier
Anne Zanchi
Marie Paule Schneider

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1294436

1,396 views
1 citation

Original Research

Published on 23 Jan 2024

Effectiveness and economic evaluation of rhTPO and rhIL-11 in the treatment of cancer therapy induced thrombocytopenia based on real-world research

in Drugs Outcomes Research and Policies

Fa-Min Gong
Fu-Yue Liu
Xue Ma
Song-Tao Ma
Hong-Tao Xiao
Gang Jiang
Ting-Ting Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1288964

997 views

Original Research

Published on 22 Jan 2024

Outpatient depression current care expenditure changes in Liaoning Province from 2015 to 2020: a study based on the “system of health accounts 2011”

in Drugs Outcomes Research and Policies

Yuedan Ma
Xiaoxia Shi
Kristin K. Sznajder
Yue Zhao
Quan Wan
Peipei Chai
Xiaoshi Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1092580

958 views

Systematic Review

Published on 22 Jan 2024

Economic evaluation of management strategies for complex regional pain syndrome (CRPS)

in Drugs Outcomes Research and Policies

Xiaofeng Zhou
Yi Zhou
Xiaofei Zhang
Feng Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1297927

1,616 views

Systematic Review

Published on 22 Jan 2024

Sociodemographic and clinical predictors of adherence to antidepressants in depressive disorders: a systematic review with a meta-analysis

in Drugs Outcomes Research and Policies

Tasmania Del Pino-Sedeño
Diego Infante-Ventura
Diego Hernández-González
Yadira González-Hernández
Beatriz González de León
Amado Rivero-Santana
Isabel Hurtado
Francisco Javier Acosta Artiles

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1327155

2,194 views
1 citation

Systematic Review

Published on 22 Jan 2024

Myopia progression after cessation of atropine in children: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Ssu-Hsien Lee
Ping-Chiao Tsai
Yu-Chieh Chiu
Jen-Hung Wang
Cheng-Jen Chiu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1343698

2,801 views

Perspective

Published on 18 Jan 2024

Education and training of clinical research professionals and the evolution of the Joint Task Force for Clinical Trial Competency

in Drugs Outcomes Research and Policies

Stephen A. Sonstein
Honorio Silva
Carolynn T. Jones
Barbara E. Bierer

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1291675

2,065 views
1 citation

Original Research

Published on 16 Jan 2024

Development and validation of a structured questionnaire for assessing risk factors of medication non-adherence among pulmonary tuberculosis patients in Indonesia

in Drugs Outcomes Research and Policies

Leonov Rianto
Ika Agustina
Sofa D. Alfian
Aulia Iskandarsyah
Ivan Surya Pradipta
Rizky Abdulah

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1257353

2,289 views

Perspective

Published on 12 Jan 2024

Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop

in Drugs Outcomes Research and Policies

Ravinder Claire
Jamie Elvidge
Shahid Hanif
Hannah Goovaerts
Peter R. Rijnbeek
Páll Jónsson
Karen Facey
Dalia Dawoud

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1289365

3,379 views
6 citations

Original Research

Published on 11 Jan 2024

Comparative price analysis of biological medicines: disparities generated by different pricing policies

in Drugs Outcomes Research and Policies

Marcela Amaral Pontes
Alane Andrelino Ribeiro
Flávia Caixeta Albuquerque
Silvana Nair Leite Cotenzini

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1256542

1,911 views
2 citations

Original Research

Published on 11 Jan 2024

Ala®sil chemical characterization and toxicity evaluation: an example of the need for the Medical Device Regulation 2017/745

in Drugs Outcomes Research and Policies

Cristina Andrés-Iglesias
Ivan Fernandez-Bueno
Salvador Pastor-Idoate
Rosa M. Coco-Martin
J. Carlos Pastor

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1310463

2,482 views

Original Research

Published on 11 Jan 2024

Impact of early heparin therapy on mortality in critically ill patients with sepsis associated acute kidney injury: a retrospective study from the MIMIC-IV database

in Drugs Outcomes Research and Policies

Zhi-Peng Zhou
Li Zhong
Yan Liu
Zhen-Jia Yang
Jia-Jia Huang
Da-Zheng Li
Yu-Hua Chen
Ying-Yi Luan
Yong-Ming Yao
Ming Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1261305

2,479 views

Original Research

Published on 09 Jan 2024

Cost-effectiveness of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with highvolume, metastatic, hormone-sensitive prostate cancer

in Drugs Outcomes Research and Policies

Huina Wu
Lei Sun
Rui Feng
Huiyue Zhang
Ke Tang
Shuo Wang
Jing Nie

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1269129

1,386 views

Correction

Published on 09 Jan 2024

Corrigendum: Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study

in Drugs Outcomes Research and Policies

Ratul Bhowmik
Ravi Kant
Ajay Manaithiya
Daman Saluja
Bharti Vyas
Ranajit Nath
Kamal A. Qureshi
Seppo Parkkila
Ashok Aspatwar

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1340724

703 views

Original Research

Published on 08 Jan 2024

Bridging the new drug access gap between China and the United States and its related policies

in Drugs Outcomes Research and Policies

Xingyue Zhu
Yang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1296737

3,000 views
2 citations

Curriculum, Instruction, and Pedagogy

Published on 08 Jan 2024

Supporting clinical research professionals through educational innovations

in Drugs Outcomes Research and Policies

Diana Lee-Chavarria
Tammy L. Loucks
Rechelle Paranal
Royce Sampson
Carol Feghali-Bostwick

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1304415

1,359 views
1 citation

Navigation group

Articles

The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study

Effectiveness and economic evaluation of rhTPO and rhIL-11 in the treatment of cancer therapy induced thrombocytopenia based on real-world research

Outpatient depression current care expenditure changes in Liaoning Province from 2015 to 2020: a study based on the “system of health accounts 2011”

Economic evaluation of management strategies for complex regional pain syndrome (CRPS)

Sociodemographic and clinical predictors of adherence to antidepressants in depressive disorders: a systematic review with a meta-analysis

Myopia progression after cessation of atropine in children: a systematic review and meta-analysis

Education and training of clinical research professionals and the evolution of the Joint Task Force for Clinical Trial Competency

Development and validation of a structured questionnaire for assessing risk factors of medication non-adherence among pulmonary tuberculosis patients in Indonesia

Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop

Comparative price analysis of biological medicines: disparities generated by different pricing policies

Ala®sil chemical characterization and toxicity evaluation: an example of the need for the Medical Device Regulation 2017/745

Impact of early heparin therapy on mortality in critically ill patients with sepsis associated acute kidney injury: a retrospective study from the MIMIC-IV database

Cost-effectiveness of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with highvolume, metastatic, hormone-sensitive prostate cancer

Corrigendum: Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study

Bridging the new drug access gap between China and the United States and its related policies

Supporting clinical research professionals through educational innovations